{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:18:48Z","timestamp":1793863128033,"version":"4.6.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009340","name":"Children's Discovery\n                    Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001021","name":"Damon Runyon Cancer\n                    Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001368","name":"V Foundation for Cancer\n                    Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001368","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nearly all chimeric antigen receptors (CARs) signal in the absence of\n                antigen, referred to as \u2018tonic signaling\u2019. Tonic signaling of CARs containing 41BB\n                domains enhances T cell fitness and function, in contrast to the exhaustion driven\n                by CD28-containing CARs. Here we show that 41BB induces BACH2, a transcriptional\n                regulator that directs stem and memory programs. Overexpression of BACH2\n                successfully prevented exhaustion but locked CAR T cells in a quiescent state. We\n                linked BACH2 to a degradation domain to tune BACH2, enabling us to prevent\n                exhaustion while enabling potent effector function that broadly enhanced the\n                long-term efficacy of CAR T cells targeting liquid and solid tumors. Through\n                interrogation of clinical CAR products, we further found an association between\n                BACH2 activity and clinical outcomes in patients with leukemia. These data identify\n                a central function for BACH2 in regulating CAR T cell efficacy.<\/jats:p>","DOI":"10.1038\/s41590-025-02391-5","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T10:03:12Z","timestamp":1768557792000},"page":"413-424","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["BACH2 regulates T cell lineage state to enhance CAR T cell\n            function"],"prefix":"10.1038","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0560-4930","authenticated-orcid":false,"given":"Tien-Ching","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7150-7998","authenticated-orcid":false,"given":"Amanda","family":"Heard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lattin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6066-5491","authenticated-orcid":false,"given":"John M.","family":"Warrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack H.","family":"Landmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangdon","family":"Tenzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishaal","family":"Ganesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryant","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Afrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepesh Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Fang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Ritchey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3478-8970","authenticated-orcid":false,"given":"Mehmet Emrah","family":"Selli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Sung","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6940-9298","authenticated-orcid":false,"given":"Haorui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. J.","family":"Federico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avery","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Meers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5039-2899","authenticated-orcid":false,"given":"Evan W.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Wandless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4096-6048","authenticated-orcid":false,"given":"Jeremy Chase","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7955-0256","authenticated-orcid":false,"given":"Paul G.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0429-3133","authenticated-orcid":false,"given":"John F.","family":"DiPersio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3991-7468","authenticated-orcid":false,"given":"Stephen","family":"Gottschalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0350-7574","authenticated-orcid":false,"given":"Nathan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"2391_CR1","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1158\/2326-6066.CIR-14-0186","volume":"3","author":"MJ Frigault","year":"2015","unstructured":"Frigault, M. J. et al. Identification of chimeric antigen receptors\n                    that mediate constitutive or inducible proliferation of T cells. Cancer Immunol. Res.\n                    3, 356\u2013367 (2015).","journal-title":"Cancer Immunol. Res."},{"key":"2391_CR2","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nm.3838","volume":"21","author":"AH Long","year":"2015","unstructured":"Long, A. H. et al. 4-1BB costimulation ameliorates T cell\n                    exhaustion induced by tonic signaling of chimeric antigen receptors. Nat. Med.\n                    21, 581\u2013590 (2015).","journal-title":"Nat. Med."},{"key":"2391_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41586-019-1805-z","volume":"576","author":"RC Lynn","year":"2019","unstructured":"Lynn, R. C. et al. c-Jun overexpression in CAR T cells induces\n                    exhaustion resistance. Nature\n                    576, 293\u2013300 (2019).","journal-title":"Nature"},{"key":"2391_CR4","doi-asserted-by":"publisher","DOI":"10.1126\/science.aba1786","volume":"372","author":"EW Weber","year":"2021","unstructured":"Weber, E. W. et al. Transient rest restores functionality in\n                    exhausted CAR-T cells through epigenetic remodeling. Science\n                    372, eaba1786 (2021).","journal-title":"Science"},{"key":"2391_CR5","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry, E. J. & Kurachi, M. Molecular and cellular insights\n                    into T cell exhaustion. Nat. Rev. Immunol.\n                    15, 486\u2013499 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"2391_CR6","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41591-021-01326-5","volume":"27","author":"N Singh","year":"2021","unstructured":"Singh, N. et al. Antigen-independent activation enhances the\n                    efficacy of 4-1BB-costimulated CD22 CAR T cells. Nat.\n                        Med.\n                    27, 842\u2013850 (2021).","journal-title":"Nat. Med."},{"key":"2391_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nm.4441","volume":"24","author":"TJ Fry","year":"2018","unstructured":"Fry, T. J. et al. CD22-targeted CAR T cells induce remission in\n                    B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy. Nat. Med.\n                    24, 20\u201328 (2018).","journal-title":"Nat. Med."},{"key":"2391_CR8","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41590-021-00868-7","volume":"22","author":"C Yao","year":"2021","unstructured":"Yao, C. et al. BACH2 enforces the transcriptional and epigenetic\n                    programs of stem-like CD8+ T cells. Nat. Immunol.\n                    22, 370\u2013380 (2021).","journal-title":"Nat. Immunol."},{"key":"2391_CR9","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/ni.3441","volume":"17","author":"R Roychoudhuri","year":"2016","unstructured":"Roychoudhuri, R. et al. BACH2 regulates\n                        CD8+ T cell differentiation by controlling access\n                    of AP-1 factors to enhancers. Nat. Immunol.\n                    17, 851\u2013860 (2016).","journal-title":"Nat. Immunol."},{"key":"2391_CR10","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1182\/blood-2012-06-438002","volume":"121","author":"W Haso","year":"2013","unstructured":"Haso, W. et al. Anti-CD22-chimeric antigen receptors targeting\n                    B-cell precursor acute lymphoblastic leukemia. Blood\n                    121, 1165\u20131174 (2013).","journal-title":"Blood"},{"key":"2391_CR11","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.immuni.2016.01.021","volume":"44","author":"OU Kawalekar","year":"2016","unstructured":"Kawalekar, O. U. et al. Distinct signaling of coreceptors regulates\n                    specific metabolism pathways and impacts memory development in CAR T cells.\n                        Immunity\n                    44, 380\u2013390 (2016).","journal-title":"Immunity"},{"key":"2391_CR12","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1016\/j.ymthe.2020.07.023","volume":"28","author":"AC Boroughs","year":"2020","unstructured":"Boroughs, A. C. et al. A distinct transcriptional program in human\n                    CAR T cells bearing the 4-1BB signaling domain revealed by scRNA-seq. Mol. Ther.\n                    28, 2577\u20132592 (2020).","journal-title":"Mol. Ther."},{"key":"2391_CR13","first-page":"3153","volume":"141","author":"ME Selli","year":"2023","unstructured":"Selli, M. E. et al. Costimulatory domains direct distinct fates of\n                    CAR-driven T-cell dysfunction. Blood\n                    141, 3153\u20133165 (2023).","journal-title":"Blood"},{"key":"2391_CR14","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1038\/s41590-024-01900-2","volume":"25","author":"W Shao","year":"2024","unstructured":"Shao, W., Wang, Y., Fang, Q., Shi, W. & Qi, H. Epigenetic\n                    recording of stimulation history reveals BLIMP1\u2013BACH2 balance in determining\n                    memory B cell fate upon recall challenge. Nat.\n                        Immunol.\n                    25, 1432\u20131444 (2024).","journal-title":"Nat. Immunol."},{"key":"2391_CR15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.immuni.2015.01.006","volume":"42","author":"GJ Martinez","year":"2015","unstructured":"Martinez, G. J. et al. The transcription factor NFAT promotes\n                    exhaustion of activated CD8+ T cells. Immunity\n                    42, 265\u2013278 (2015).","journal-title":"Immunity"},{"key":"2391_CR16","doi-asserted-by":"publisher","first-page":"10735","DOI":"10.1073\/pnas.1306691110","volume":"110","author":"S-I Tsukumo","year":"2013","unstructured":"Tsukumo, S.-I. et al. Bach2 maintains T cells in a naive state by\n                    suppressing effector memory-related genes. Proc. Natl\n                        Acad. Sci. USA\n                    110, 10735\u201310740 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2391_CR17","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nri3307","volume":"12","author":"SM Kaech","year":"2012","unstructured":"Kaech, S. M. & Cui, W. Transcriptional control of effector and\n                    memory CD8+ T cell differentiation. Nat. Rev.\n                        Immunol.\n                    12, 749\u2013761 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"2391_CR18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.immuni.2015.12.006","volume":"44","author":"J Godec","year":"2016","unstructured":"Godec, J. et al. Compendium of immune signatures identifies\n                    conserved and species-specific biology in response to inflammation. Immunity\n                    44, 194\u2013206 (2016).","journal-title":"Immunity"},{"key":"2391_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23324-4","volume":"12","author":"M Andreatta","year":"2021","unstructured":"Andreatta, M. et al. Interpretation of T cell states from\n                    single-cell transcriptomics data using reference atlases. Nat. Commun.\n                    12, 2965 (2021).","journal-title":"Nat. Commun."},{"key":"2391_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.immuni.2009.11.012","volume":"32","author":"ME Pipkin","year":"2010","unstructured":"Pipkin, M. E. et al. Interleukin-2 and inflammation induce distinct\n                    transcriptional programs that promote the differentiation of effector cytolytic\n                    T cells. Immunity\n                    32, 79\u201390 (2010).","journal-title":"Immunity"},{"key":"2391_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.immuni.2009.11.010","volume":"32","author":"V Kalia","year":"2010","unstructured":"Kalia, V. et al. Prolonged interleukin-2R\u03b1 expression on\n                    virus-specific CD8+ T cells favors terminal-effector\n                    differentiation in vivo. Immunity\n                    32, 91\u2013103 (2010).","journal-title":"Immunity"},{"key":"2391_CR22","doi-asserted-by":"publisher","first-page":"101954","DOI":"10.1016\/j.xpro.2022.101954","volume":"4","author":"ME Selli","year":"2023","unstructured":"Selli, M. E., Landmann, J. H., Arveseth, C. & Singh, N.\n                    Inducing T cell dysfunction by chronic stimulation of CAR-engineered T cells\n                    targeting cancer cells in suspension cultures. STAR\n                        Protoc.\n                    4, 101954 (2023).","journal-title":"STAR Protoc."},{"key":"2391_CR23","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1084\/jem.20052237","volume":"203","author":"A Jabbari","year":"2006","unstructured":"Jabbari, A. & Harty, J. T. Secondary memory\n                        CD8+ T cells are more protective but slower to\n                    acquire a central-memory phenotype. J. Exp.\n                        Med.\n                    203, 919\u2013932 (2006).","journal-title":"J. Exp. Med."},{"key":"2391_CR24","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.immuni.2011.03.020","volume":"34","author":"JC Nolz","year":"2011","unstructured":"Nolz, J. C. & Harty, J. T. Protective capacity of memory\n                        CD8+ T cells is dictated by antigen exposure\n                    history and nature of the infection. Immunity\n                    34, 781\u2013793 (2011).","journal-title":"Immunity"},{"key":"2391_CR25","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.chembiol.2010.07.009","volume":"17","author":"M Iwamoto","year":"2010","unstructured":"Iwamoto, M., Bj\u00f6rklund, T., Lundberg, C., Kirik, D. & Wandless,\n                    T. J. A general chemical method to regulate protein stability in the mammalian\n                    central nervous system. Chem. Biol.\n                    17, 981\u2013988 (2010).","journal-title":"Chem. Biol."},{"key":"2391_CR26","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ccell.2015.09.004","volume":"28","author":"Z Zhao","year":"2015","unstructured":"Zhao, Z. et al. Structural design of engineered costimulation\n                    determines tumor rejection kinetics and persistence of CAR T cells. Cancer Cell\n                    28, 415\u2013428 (2015).","journal-title":"Cancer Cell"},{"key":"2391_CR27","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41591-018-0010-1","volume":"24","author":"JA Fraietta","year":"2018","unstructured":"Fraietta, J. A. et al. Determinants of response and resistance to\n                    CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic\n                    leukemia. Nat. Med.\n                    24, 563\u2013571 (2018).","journal-title":"Nat. Med."},{"key":"2391_CR28","doi-asserted-by":"publisher","first-page":"320ra3","DOI":"10.1126\/scitranslmed.aad5222","volume":"8","author":"N Singh","year":"2016","unstructured":"Singh, N., Perazzelli, J., Grupp, S. A. & Barrett, D. M. Early\n                    memory phenotypes drive T cell proliferation in patients with pediatric\n                    malignancies. Sci. Transl. Med.\n                    8, 320ra3 (2016).","journal-title":"Sci. Transl. Med."},{"key":"2391_CR29","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1038\/s41591-020-1061-7","volume":"26","author":"Q Deng","year":"2020","unstructured":"Deng, Q. et al. Characteristics of anti-CD19 CAR T cell infusion\n                    products associated with efficacy and toxicity in patients with large B cell\n                    lymphomas. Nat. Med.\n                    26, 1878\u20131887 (2020).","journal-title":"Nat. Med."},{"key":"2391_CR30","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1158\/2159-8290.CD-20-1677","volume":"11","author":"GM Chen","year":"2021","unstructured":"Chen, G. M. et al. Integrative bulk and single-cell profiling of\n                    premanufacture T-cell populations reveals factors mediating long-term\n                    persistence of CAR T-cell therapy. Cancer\n                        Discov.\n                    11, 2186\u20132199 (2021).","journal-title":"Cancer Discov."},{"key":"2391_CR31","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1158\/2159-8290.CD-21-1508","volume":"12","author":"TL Wilson","year":"2022","unstructured":"Wilson, T. L. et al. Common trajectories of highly effective\n                    CD19-specific CAR T cells identified by endogenous T-cell receptor lineages.\n                        Cancer Discov.\n                    12, 2098\u20132119 (2022).","journal-title":"Cancer Discov."},{"key":"2391_CR32","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran, D. et al. Reference-based analysis of lung single-cell\n                    sequencing reveals a transitional profibrotic macrophage. Nat. Immunol.\n                    20, 163\u2013172 (2019).","journal-title":"Nat. Immunol."},{"key":"2391_CR33","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/s41592-023-01938-4","volume":"20","author":"C Bravo Gonz\u00e1lez-Blas","year":"2023","unstructured":"Bravo Gonz\u00e1lez-Blas, C. et al. SCENIC+: single-cell multiomic\n                    inference of enhancers and gene regulatory networks. Nat. Methods\n                    20, 1355\u20131367 (2023).","journal-title":"Nat. Methods"},{"key":"2391_CR34","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1056\/NEJMoa1709866","volume":"378","author":"SL Maude","year":"2018","unstructured":"Maude, S. L. et al. Tisagenlecleucel in children and young adults\n                    with B-cell lymphoblastic leukemia. N. Engl. J.\n                        Med.\n                    378, 439\u2013448 (2018).","journal-title":"N. Engl. J. Med."},{"key":"2391_CR35","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1200\/JCO.22.00642","volume":"41","author":"TW Laetsch","year":"2023","unstructured":"Laetsch, T. W. et al. Three-year update of tisagenlecleucel in\n                    pediatric and young adult patients with relapsed\/refractory acute lymphoblastic\n                    leukemia in the ELIANA trial. J. Clin. Oncol.\n                    41, 1664\u20131669 (2023).","journal-title":"J. Clin. Oncol."},{"key":"2391_CR36","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0140-6736(24)00746-3","volume":"404","author":"MJ Frank","year":"2024","unstructured":"Frank, M. J. et al. CD22-directed CAR T-cell therapy for large\n                    B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a\n                    dose-finding phase 1 study. Lancet\n                    404, 353\u2013363 (2024).","journal-title":"Lancet"},{"key":"2391_CR37","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-021-04390-6","volume":"602","author":"JJ Melenhorst","year":"2022","unstructured":"Melenhorst, J. J. et al. Decade-long leukaemia remissions with\n                    persistence of CD4+ CAR T cells. Nature\n                    602, 503\u2013509 (2022).","journal-title":"Nature"},{"key":"2391_CR38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1158\/2326-6066.CIR-17-0211","volume":"6","author":"SA Richman","year":"2018","unstructured":"Richman, S. A. et al. High-affinity GD2-specific CAR T cells induce\n                    fatal encephalitis in a preclinical neuroblastoma model. Cancer Immunol. Res.\n                    6, 36\u201346 (2018).","journal-title":"Cancer Immunol. Res."},{"key":"2391_CR39","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41586-024-07242-1","volume":"629","author":"JD Chan","year":"2024","unstructured":"Chan, J. D. et al. FOXO1 enhances CAR T cell stemness, metabolic\n                    fitness and efficacy. Nature\n                    629, 201\u2013210 (2024).","journal-title":"Nature"},{"key":"2391_CR40","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41586-024-07300-8","volume":"629","author":"AE Doan","year":"2024","unstructured":"Doan, A. E. et al. FOXO1 is a master regulator of memory\n                    programming in CAR T cells. Nature\n                    629, 211\u2013218 (2024).","journal-title":"Nature"},{"key":"2391_CR41","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/PPO.0000000000000036","volume":"20","author":"SR Riddell","year":"2014","unstructured":"Riddell, S. R. et al. Adoptive therapy with chimeric antigen\n                    receptor-modified T cells of defined subset composition. Cancer J.\n                    20, 141\u2013144 (2014).","journal-title":"Cancer J."},{"key":"2391_CR42","doi-asserted-by":"publisher","first-page":"101212","DOI":"10.1016\/j.omtm.2024.101212","volume":"32","author":"C Amatya","year":"2024","unstructured":"Amatya, C. et al. Optimization of anti-CD19 CAR T cell production\n                    for treatment of patients with chronic lymphocytic leukemia. Mol. Ther. Methods Clin. Dev.\n                    32, 101212 (2024).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"2391_CR43","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.3389\/fimmu.2020.01217","volume":"11","author":"S Arcangeli","year":"2020","unstructured":"Arcangeli, S. et al. Next-generation manufacturing protocols\n                    enriching TSCM CAR T cells can overcome disease-specific T cell defects in\n                    cancer patients. Front. Immunol.\n                    11, 1217 (2020).","journal-title":"Front. Immunol."},{"key":"2391_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/science.abn5647","volume":"378","author":"KA Freitas","year":"2022","unstructured":"Freitas, K. A. et al. Enhanced T cell effector activity by\n                    targeting the mediator kinase module. Science\n                    378, eabn5647 (2022).","journal-title":"Science"},{"key":"2391_CR45","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1038\/s41596-022-00692-9","volume":"17","author":"FC Grandi","year":"2022","unstructured":"Grandi, F. C., Modi, H., Kampman, L. & Corces, M. R. Chromatin\n                    accessibility profiling by ATAC-seq. Nat.\n                        Protoc.\n                    17, 1518\u20131552 (2022).","journal-title":"Nat. Protoc."},{"key":"2391_CR46","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/bioinformatics\/btab507","volume":"38","author":"F Yu","year":"2021","unstructured":"Yu, F., Sankaran, V. G. & Yuan, G.-C. CUT&RUNTools 2.0: a\n                    pipeline for single-cell and bulk-level CUT&RUN and CUT&Tag data\n                    analysis. Bioinformatics\n                    38, 252\u2013254 (2021).","journal-title":"Bioinformatics"},{"key":"2391_CR47","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with\n                    Bowtie 2. Nat. Methods\n                    9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"2391_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol.\n                    9, R137 (2008).","journal-title":"Genome Biol."},{"key":"2391_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of\n                    fold change and dispersion for RNA-seq data with DESeq2. Genome Biol.\n                    15, 550 (2014).","journal-title":"Genome Biol."},{"key":"2391_CR50","doi-asserted-by":"publisher","first-page":"e585","DOI":"10.1002\/cpz1.585","volume":"2","author":"Q Wang","year":"2022","unstructured":"Wang, Q. et al. Exploring epigenomic datasets by ChIPseeker.\n                        Curr. Protoc.\n                    2, e585 (2022).","journal-title":"Curr. Protoc."},{"key":"2391_CR51","doi-asserted-by":"publisher","first-page":"5737","DOI":"10.1182\/bloodadvances.2021006293","volume":"6","author":"AC Talleur","year":"2022","unstructured":"Talleur, A. C. et al. Preferential expansion of\n                        CD8+ CD19-CAR T cells postinfusion and the role\n                    of disease burden on outcome in pediatric B-ALL. Blood\n                        Adv.\n                    6, 5737\u20135749 (2022).","journal-title":"Blood Adv."}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02391-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02391-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02391-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T08:03:32Z","timestamp":1773216212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02391-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2391"],"URL":"https:\/\/doi.org\/10.1038\/s41590-025-02391-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5845875\/v1","asserted-by":"object"}]},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"16 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article was originally published under the subscription\n                        model but it is now published under an Open Access license.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.E.S. is currently an employee of Wugen. E.W.W. holds equity in\n                    Lyell Immunopharma and consults for Umoja Immunopharma. T.J.W. is a founder and\n                    consultant for Obsidian Therapeutics. J.F.D. receives research funding from\n                    Amphivena Therapeutics, NeoImmuneTech, Macrogenics, Incyte, Bioline Rx and\n                    Wugen; has equity ownership in Magenta Therapeutics and Wugen; consults for\n                    Incyte, RiverVest Venture Partners and hC Bioscience, Inc.; and is a board\n                    member for Magenta Therapeutics. J.C.C. and P.G.T. have patents related to\n                    cellular immunotherapy. S.G. is a co-inventor on patents and patent applications\n                    in the fields of gene and cell therapy for cancer, a member of the Scientific\n                    Advisory Board of Be Biopharma and a Data Safety Monitoring Board member of\n                    Immatics and has received honoraria from CARGO Therapeutics within the last\n                    year. N.S. holds equity in Phoreus Bio and Defiance Therapeutics and has patents\n                    and patent applications in the field of cellular immunotherapy. T.-C.C. and N.S.\n                    have submitted patent applications related to this work. The other authors\n                    declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}